Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,372 | 342 | 92.9% |
| Education | $180.44 | 8 | 3.1% |
| Consulting Fee | $125.00 | 1 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $105.00 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $890.55 | 72 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $622.95 | 39 | $0 (2018) |
| Lilly USA, LLC | $536.48 | 36 | $0 (2022) |
| Amgen Inc. | $535.60 | 29 | $0 (2018) |
| Shire North American Group Inc | $361.24 | 10 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $356.24 | 33 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $332.64 | 22 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $279.57 | 14 | $0 (2018) |
| Abbott Laboratories | $217.26 | 11 | $0 (2021) |
| Tandem Diabetes Care, Inc. | $154.68 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.07 | 2 | Novo Nordisk Inc ($14.96) |
| 2023 | $147.51 | 1 | Actelion Pharmaceuticals US, Inc. ($147.51) |
| 2022 | $306.58 | 10 | Novo Nordisk Inc ($169.87) |
| 2021 | $13.21 | 1 | Abbott Laboratories ($13.21) |
| 2020 | $150.00 | 4 | Esperion Therapeutics, Inc. ($150.00) |
| 2019 | $210.27 | 2 | Tandem Diabetes Care, Inc. ($105.27) |
| 2018 | $1,962 | 113 | Amgen Inc. ($343.84) |
| 2017 | $2,973 | 219 | Novo Nordisk Inc ($378.09) |
All Payment Transactions
352 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $5.11 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 06/15/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $147.51 | General |
| Category: Cardiology | ||||||
| 10/24/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: Diabetes | ||||||
| 10/18/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: Diabetes | ||||||
| 10/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Diabetes | ||||||
| 09/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Diabetes | ||||||
| 08/23/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 06/09/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 05/03/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $93.34 | General |
| Category: Diabetes | ||||||
| 04/19/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Diabetes | ||||||
| 02/13/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 02/01/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Diabetes | ||||||
| 12/26/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diabetes Care | ||||||
| 11/03/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $40.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/03/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $35.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/02/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $40.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/02/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $35.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/05/2019 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Food and Beverage | Cash or cash equivalent | $105.27 | General |
| Category: Endocrinology | ||||||
| 05/08/2019 | GENZYME CORPORATION | SOLIQUA 100/33 (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $105.00 | General |
| Category: DIABETES | ||||||
| 11/23/2018 | Abbott Laboratories | FreeStyle Libre Pro (Device) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: Diabetes Care | ||||||
| 07/19/2018 | Abbott Laboratories | FreeStyle Libre blood glucose Flash Monitoring System (Device) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Diabetes Care | ||||||
| 07/19/2018 | Abbott Laboratories | FreeStyle Libre blood glucose Flash Monitoring System (Device) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: Diabetes Care | ||||||
| 07/11/2018 | Abbott Laboratories | FreeStyle Libre blood glucose Flash Monitoring System (Device) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: Diabetes Care | ||||||
| 06/20/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 572 | 2,320 | $235,225 | $66,201 |
| 2022 | 8 | 589 | 2,390 | $230,082 | $65,022 |
| 2021 | 8 | 595 | 2,337 | $233,582 | $65,732 |
| 2020 | 12 | 766 | 2,616 | $260,067 | $62,332 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 326 | $94,866 | $27,407 | 28.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 15 | 1,320 | $80,520 | $24,396 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $18,081 | $4,441 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 51 | $10,251 | $2,844 | 27.7% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 19 | 56 | $10,920 | $2,240 | 20.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 113 | 229 | $8,015 | $2,152 | 26.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 35 | 67 | $8,442 | $1,682 | 19.9% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 109 | 204 | $2,856 | $774.23 | 27.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 26 | $1,274 | $265.50 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 191 | 330 | $96,030 | $28,814 | 30.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 19 | 1,440 | $86,490 | $24,106 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $17,199 | $4,264 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 61 | $12,261 | $3,498 | 28.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 127 | 230 | $8,050 | $2,121 | 26.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 23 | 46 | $5,796 | $1,124 | 19.4% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 122 | 220 | $3,080 | $831.63 | 27.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 24 | $1,176 | $263.87 | 22.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 201 | 355 | $103,305 | $30,738 | 29.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 14 | 1,320 | $80,520 | $21,717 | 27.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 38 | 38 | $16,758 | $4,497 | 26.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 73 | $14,673 | $4,313 | 29.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 122 | 242 | $8,470 | $2,251 | 26.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 22 | 40 | $5,040 | $1,025 | 20.3% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 121 | 239 | $3,346 | $895.55 | 26.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 30 | $1,470 | $295.38 | 20.1% |
About Dhaval Patel
Dhaval Patel is a Internal Medicine healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902966591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dhaval Patel has received a total of $5,783 in payments from pharmaceutical and medical device companies, with $20.07 received in 2024. These payments were reported across 352 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,372).
As a Medicare-enrolled provider, Patel has provided services to 2,522 Medicare beneficiaries, totaling 9,663 services with total Medicare billing of $259,287. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location High Point, NC
- Active Since 12/12/2006
- Last Updated 01/31/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902966591
Products in Payments
- FARXIGA (Drug) $622.95
- Ozempic (Drug) $407.99
- NATPARA (Drug) $361.24
- Prolia (Biological) $331.46
- INVOKANA (Drug) $330.56
- JARDIANCE (Drug) $307.42
- Victoza (Drug) $271.77
- Repatha (Biological) $204.14
- TOUJEO (Drug) $190.50
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $165.19
- t-slim insulin pump (Device) $154.68
- BASAGLAR (Drug) $152.76
- NEXLETOL (Drug) $150.00
- UPTRAVI (Drug) $147.51
- SOLIQUA (Drug) $142.14
- JANUVIA (Drug) $137.57
- Korlym (Drug) $129.89
- Dexcom G5 Mobile CGM System (Device) $126.01
- MOUNJARO (Drug) $125.00
- SOLIQUA 100/33 (Drug) $105.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in High Point
Imran Haque, M.d, M.D
Internal Medicine — Payments: $18,695
Dr. Jeffrey Yourshaw, M.d, M.D
Internal Medicine — Payments: $12,650
Dr. Oscar Florendo, M.d, M.D
Internal Medicine — Payments: $11,971
Thomas Jarrett, M.d, M.D
Internal Medicine — Payments: $9,588
Kurt Daniel, D.o, D.O
Internal Medicine — Payments: $7,198
Dr. William Smith, M.d, M.D
Internal Medicine — Payments: $6,941